The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers

Japanese Journal of Cancer Research

Volumn 87, Issue 12, 1996, Pages 1263-1270

  Tomonaga, Michio ^a   Oka, Mikio ^a   Narasaki, Fumihiko ^a   Fukuda, Minoru ^a   Nakano, Reiji ^a   Takatani, Hiroshi ^a   Ikeda, Koki ^a   Terashi, Kenji ^a   Matsuo, Isao ^a   Soda, Hiroshi ^a   Cowan, Kenneth H ^b   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Colon cancer; Gastric cancer; Modulating agent; MRP; Multidrug resistance

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ANTINEOPLASTIC AGENT; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; MESSENGER RNA; VERAPAMIL; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; DRUG SENSITIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER;

EID: 12644262383     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb03142.x     Document Type: Article

References (46)

1. Pastan, I. and Gottesman, M. M. Multiple-drug resistance in human cancer. N. Engl. J. Med., 316, 1388-1393 (1987).
2. Alexander, H. R., Kelsen, D. P. and Tepper, J. E. Cancer of the stomach. In "Cancer: Principles and Practice of Oncology, 4th Ed.," ed. V. T. DeVita, Jr., S. Hellman and S. A. Rosenberg, pp. 818-848 (1993). Lippincott, Philadelphia.
3. Cohen, A. M., Minsky, B. D. and Schilsky, R. L. Colon cancer. In "Cancer: Principles and Practice of Oncology, 4th Ed.," ed. V. T. DeVita, Jr., S. Hellman and S. A. Rosenberg, pp. 929-977 (1993). Lippincott, Philadelphia.
4. Gottesman, M. M. and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62, 385-427 (1993).
5. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M. and Pastan, I. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA, 84, 7735-7738 (1987).
6. Weinstein, R. S., Kuszak, J. R., Kluskens, L. F., Kluskens, L. F. and Coon, J. S. P-glycoproteins in pathology: the multidrug resistance gene family in humans. Hum. Pathol., 21, 34-48 (1990).
7. Cordon-Cardo, C., O'Brien, J. P., Boccia, J., Casals, D., Bertino, J. R. and Melamed, M. R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem., 38, 1277-1287 (1990).
8. Moscow, J. A., Fairchild, C. R., Madden, M. J., Ransom, D. T., Wieand, H. S. and Cowan, K. H. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res., 49, 1422-1428 (1989).
9. Wallner, J., Depisch, D., Gsur, A., Gotzl, M., Haider, K. and Pirker, R. MDR1 gene expression and its clinical relevance in primary gastric carcinoma. Cancer, 71, 667-671 (1993).
10. Center, M. S. Non-P-glycoprotein multidrug resistance in cell lines which are defective in the cellular accumulation of drug. Cytotechnology, 12, 109-125 (1993).
11. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V. and Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654 (1992).
12. Fan, D., Bielenberg, D. R., Wang, Y., Radinsky, R. and Beltran, P. J. The multidrug resistance-associated protein-MRP. In "Alternative Mechanisms of Multidrug Resistance in Cancer," ed. J. A. Kellen, pp. 81-94 (1995). Birkhäuser, Boston.
13. Sumizawa, T., Chuman, Y., Sakamoto, H., Iemura, K., Almquist, K. C., Deeley, R. G., Cole, S. P. C. and Akiyama, S. Non-p-glycoprotein-mediated multidrug-resistant human KB cells selected in medium containing adriamycin, cepharanthine, and mezerein. Somatic Cell Mol. Genet., 20, 423-435 (1994).
14. Koike, K., Abe, T., Hisano, T., Kubo, T., Wada, M., Kohno, K. and Kuwano, M. Overexpression of multidrug resistance protein gene in human cancer cell lines selected for drug resistance to epipodophyllotoxins. Jpn. J. Cancer Res., 87, 765-772 (1996).
15. Zaman, G. J. R., Versantvoort, C. H. M., Smit, J. J. M., Eijdems, E. W. H. M., de Haas, M., Smith, A. J., Broxterman, H. J., Mülder, N. H., de Vries, E. G. E., Baas, F. and Borst, P. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res., 53, 1747-1750 (1993).
16. Slapak, C. A., Mizunuma, N. and Kufe, D. W. Expression of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells. Blood, 84, 3113-3121 (1994).
17. Davey, R. A., Longhurst, T. J., Davey, M. W., Belov, L., Harvie, R. M., Hancox, D. and Wheeler, H, Drug resistance mechanisms and MRP expression in response to epirubicin treatment in a human leukemia cell line. Leukemia Res., 19, 275-282 (1995).
18. Doyle, L. A., Ross, D. D., Ordonez, J. V., Yang, W., Gao, Y., Tong, Y., Belani, C. P. and Gutheil, J. C. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein. Br. J. Cancer, 72, 535-542 (1995).
19. Zaman, G. J., Flens, M. J., van Leusden, M. R., de Haas, M., Mülder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., Broxterman, H. J. and Borst, P. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. USA, 91, 8822-8826 (1994).
20. Grant, C. E., Valdimarsson, G., Hipfner, D. R., Almquist, K. C., Cole, S. P. C. and Deeley, R. O. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res., 54, 357-361 (1994).
21. Kruh, G. D., Chan, A., Myers, K., Gaughan, K., Miki, T. and Aaronson, S. A. Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene. Cancer Res., 54, 1649-1652 (1994).
22. Cole, S. P. C., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M. and Deeley, R. G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 54, 5902-5910 (1994).
23. Barrand, M. A., Rhodes, T., Center, M. S. and Twenty-man, P. R. Chemosensitization and drug accumulation effects of cyclosporin A, PSC-833 and Verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein. Eur. J. Cancer, 29, 408-415 (1993).
24. Abbaszadegan, M. R., Futscher, B. W., Klimecki, W. T., List, A. and Dalton, W. S. Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res., 54, 4676-4679 (1994).
25. Schneider, E., Cowan, K. H., Bader, H., Toomey, S., Schwartz, G. N., Karp, J. E., Burke, P. J. and Kaufmann, S. H. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood, 85, 186-193 (1995).
26. Kruh, G. D., Gaughan, K. T., Godwin, A. and Chan, A. Expression pattern of MRP in human tissues and adult solid tumor cell lines. J. Natl. Cancer Inst., 87, 1256-1258 (1995).
27. Nooter, K., Westerman, A. M., Flens, M. J., Zaman, G. J. R., Scheper, R. J., van Wingerden, K. E., Burger, H., Oostrum, R., Boersma, T., Sonneveld, P., Gratama, J. W., Kok, T., Eggermont, A. M. M., Bosman, F. T. and Stoter, G. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin. Cancer Res., 1, 1301-1310 (1995).
28. Flens, M. J., Izquierdo, M. A., Scheffer, G. L., Fritz, J. M., Meijer, C. J. L. M., Scheper, R. J. and Zaman, G. J. R. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res., 54, 4557-4563 (1994).
29. Narasaki, F., Matsuo, I., Ikuno, N., Fukuda, M., Soda, H. and Oka, M. Multidrug resistance-associated protein gene expression in human lung cancer. Anticancer Res., 16, 2079-2082 (1996).
30. Chuman, Y., Sumizawa, T., Takebayashi, Y., Niwa, K., Yamada, K., Haraguchi, M., Furukawa, T., Akiyama, S. and Aikou, T. Expression of the multidrug-resistance-associated protein (MRP) gene in human colorectal, gastric, and non-small-cell lung carcinomas. Int. J. Cancer, 66, 274-279 (1996).
31. Fairchild, C. R., Ivy, S. P., Kao-Shan, C.-S., Whang-Peng, J., Rosen, N., Israel, M. A., Melera, P. W., Cowan, K. H. and Goldsmith, M. E. Isolation of amplified and overexpressed DNA sequences from Adriamycin-resistant human breast cancer cells. Cancer Res., 47, 5141-5148 (1987).
32. Chomczynski, P. and Sacchi, N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenolchloroform extraction. Anal. Biochem., 162, 156-159 (1987).
33. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63 (1983).
34. Goldstein, L. J., Galski, H., Fojo, A. T., Willingham, M., Lai, S. L. and Pastan, I. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst., 81, 116-124 (1989).
35. Dietel, M., Arps, H., Lage, H. and Niendorf, A. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257. Cancer Res., 50, 6100-6106 (1990).
36. Dalton, W. S., Cress, A. E., Alberts, D. S. and Trent, J. M. Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone. Cancer Res., 48, 1882-1888 (1988).
37. Brock, L, Hipfner, D. R., Nielsen, B. S., Jensen, P. B., Deeley, R. G., Cole, S. P. C. and Sehested, M. Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells. Cancer Res., 55, 459-462 (1995).
38. Burger, H., Nooter, K., Sonneveld, P., van Wingerden, K. E., Zaman, G. J. R. and Stoter, G. High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukemia. Br. J. Haematol., 88, 348-356 (1994).
39. Schuurhuis, G. J., Broxterman, H. J., Ossenkoppele, G. J., Baak, J. P. A., Eekman, C. A., Kuiper, C. M., Feller, N., van Heijningen, T. H. M., Klumper, E., Pieters, R., Lankelma, J. and Pinedo, H. M. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-β-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia. Clin. Cancer Res., 1, 81-93 (1995).
40. Burger, H., Nooter, K., Zaman, G. J., Sonneveld, P., van Wingerden, K. E., Oostrum, R. G. and Stoter, G. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. Leukemia, 8, 990-997 (1994).
41. Takano, H., Kohno, K., Matsuo, K., Matsuda, T. and Kuwano, M. DNA topoisomerase-targeting antitumor agents and drug resistance. Anti-Cancer Drugs, 3, 323-330 (1992).
42. Jedlitschky, G., Leier, L, Buchholz, U., Center, M. and Keppler, D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res., 54, 4833-4836 (1994).
43. Müller, M., Meijer, C., Zaman, O. J. R., Borst, P., Scheper, R. J., Mülder, N. H., de Vries, E. G. E. and Jansen, P. L. M. Overexpression of the multidrug resistance associated protein (MRP) gene results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA, 91, 13033-13037 (1994).
44. Zaman, G. J. R., Lankelma, J., van Tellingen, O., Beijnen, J., Dekker, H., Paulusma, C., Oude Elferink, R. P., Baas, F. and Borst, P. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc. Natl. Acad. Sci. USA, 92, 7690-7694 (1995).
45. 4 and chemotherapeutic agents in membrane vesicles. J. Biol. Chem., 271, 9675-9682 (1996).
46. Schneider, E., Yamazaki, H., Sinha, B. K. and Cowan, K. H. Buthionine sulphoximitie-mediated sensitization of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation. Br. J. Cancer, 71, 738-743 (1995).